1[1]Sapy T,Szikszay A,Konya J,et al.Prevalence of human Papillomavirus infections in our five year Data[J].Orv Hetil,2001; 142 (24):1265-1268.
2[2]Bosch FX,de Sanjose S.Human papillomavirus in cervical cancer[J].Curr Oncol Rep,2002;4(2):175-183.
3[3]Pirog EC,Isacson C,Szabolcs M J,et al.Proliferative activity of benign and neoplastic endocervical epithelium and correlation with HPV DNA detection[J].Int J Gynecol Pathol,2002; 21(1):22-26.
4[4]Wallin KL,Wiklund F,Angstrom T,et al.Typespecific persistence of human papillomavirus DNA before the development of invasive cervical cancer[J].N Engl J Med,1999; 341 (22):1633-1638.
5[5]Tjiong MY,Out TA,Ter Schegget J,et al.Epidemiologic and mucosal immunoiogic aspects of HPV infection and HPV-related cervical neoplasia in the lower female genital tract:a review[J].Int J Gynecol Cancer,2001;11(1):9-17.
6[6]Paez C,Sato S,et al.HPV,histologic grade and age.Risk factors for the progression of cervical intraepithelial neoplasia[J].J Reprod Med,1998;43(7):561-566.
7[7]Koromilas AE,LIs,Matlashewski G.Contror of interferon Signaling in human papillomavirus infection[J].Cytokine Growth factor Rev,2001; 12(3):157.
8[8]Tjiong MY,Zumbach K,Schegget JT,et al.Antibodies against human papillomavirus type 16 and 18 E6 and E7 proteins in cervicovaginal washings and serum of patients with cervical neoplasia[J].Viral Immunol,2001; 14 (4):415-424.
